David Porter, MD, on Researching CAR-T to Bring to Autoimmune Disease and Beyond
The director of Cell Therapy and Transplant at Penn Medicine discussed his outlook on CAR T-cell therapy research and the future.
David Porter, MD, on Preparing for CAR-T's Use in Autoimmune Diseases
The director of Cell Therapy and Transplant at Penn Medicine discussed important considerations with administering CAR-T in a new field.
David Porter, MD, on Enabling the Expansion of CAR T to Autoimmune Diseases
The director of Cell Therapy and Transplant at Penn Medicine discussed how experience with CAR T in oncology has enabled the use of the technology in autoimmune diseases.
David Porter, MD, on Adopting CAR T-Cell Therapy for Autoimmune Disease
The director of Cell Therapy and Transplant at Penn Medicine discussed the potential of CAR T-cell therapy to benefit patients with diseases including Lupus nephritis.
David Porter, MD, on the Importance of Collaboration for Investigating Cell Therapy in Autoimmune Disease
The director of cell therapy and transplant at Penn Medicine discussed the seminar he gave at the inaugural Cell Therapy for Autoimmune Disease Summit.
The Promise of Chimeric Antigen Receptor T-Cell Therapy
In this review, we will describe the mechanism of action of CAR T cells, discuss outcomes of current clinical trials, and highlight emerging directions for this exciting approach to cancer treatment.